ResMed Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
ResMed Inc. (RMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $25.00 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-13
- ResMed Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2017-06-30 was $8.20M, a 127.78% increase year-over-year.
- ResMed Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2017-03-31 was $6.20M, a 46.09% decline year-over-year.
- ResMed Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2016-12-31 was $4.90M, a 70.12% decline year-over-year.
- ResMed Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2016-09-30 was $8.80M, a 1.12% decline year-over-year.
- ResMed Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2026 was $25.00M, a 34.21% decline from fiscal 2025.
- ResMed Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $38.00M, a 111.11% increase from fiscal 2024.
- ResMed Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $18.00M, a 29.13% decline from fiscal 2023.
- ResMed Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $25.40M, a 24.63% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $25.00M 10-K · filed 2026-08-13 | ||||
| 2025-06-30 | $38.00M 10-K · filed 2026-08-13 | $37.70M 10-K · filed 2025-08-08 | |||
| 2024-06-30 | $18.00M 10-K · filed 2026-08-13 | $17.90M 10-K · filed 2024-08-09 | |||
| 2023-06-30 | $25.40M 10-K · filed 2025-08-08 | ||||
| 2022-06-30 | $33.70M 10-K · filed 2024-08-09 | ||||
| 2021-06-30 | $8.90M 10-K · filed 2023-08-11 | ||||
| 2020-06-30 | $31.20M 10-K · filed 2022-08-12 | ||||
| 2019-06-30 | $15.10M 10-K · filed 2021-08-17 | ||||
| 2018-06-30 | $27.50M 10-K · filed 2020-08-13 | ||||
| 2017-06-30 | $8.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-08 | $14.40M derived: sum of 2 quarters · filed 2019-08-08 | $19.30M derived: sum of 3 quarters · filed 2019-08-08 | $28.10M 10-K · filed 2019-08-08 | |
| 2017-03-31 | $6.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-28 | $11.10M derived: sum of 2 quarters · filed 2017-04-28 | $19.90M 10-Q · filed 2017-04-28 | $23.50M derived: sum of 4 quarters · filed 2018-08-17 | |
| 2016-12-31 | $4.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-25 | $13.70M 10-Q · filed 2017-01-25 | $17.30M derived: sum of 3 quarters · filed 2018-08-17 | $28.80M derived: sum of 4 quarters · filed 2018-08-17 | |
| 2016-09-30 | $8.80M 10-Q · filed 2016-10-28 | $12.40M derived: sum of 2 quarters · filed 2018-08-17 | $23.90M derived: sum of 3 quarters · filed 2018-08-17 | $40.30M derived: sum of 4 quarters · filed 2018-08-17 | |
| 2016-06-30 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-17 | $15.10M derived: sum of 2 quarters · filed 2018-08-17 | $31.50M derived: sum of 3 quarters · filed 2018-08-17 | $40.40M 10-K · filed 2018-08-17 | |
| 2016-03-31 | $11.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-28 | $27.90M derived: sum of 2 quarters · filed 2017-04-28 | $36.80M 10-Q · filed 2017-04-28 | $53.00M derived: sum of 4 quarters · filed 2017-08-04 | |
| 2015-12-31 | $16.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-25 | $25.30M 10-Q · filed 2017-01-25 | $41.50M derived: sum of 3 quarters · filed 2017-08-04 | $77.00M derived: sum of 4 quarters · filed 2017-08-04 | |
| 2015-09-30 | $8.90M 10-Q · filed 2016-10-28 | $25.10M derived: sum of 2 quarters · filed 2017-08-04 | $60.60M derived: sum of 3 quarters · filed 2017-08-04 | $79.40M derived: sum of 4 quarters · filed 2017-08-04 | |
| 2015-06-30 | $16.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-04 | $51.70M derived: sum of 2 quarters · filed 2017-08-04 | $70.50M derived: sum of 3 quarters · filed 2017-08-04 | $80.20M 10-K · filed 2017-08-04 | |
| 2015-03-31 | $35.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-04-29 | $54.30M derived: sum of 2 quarters · filed 2016-04-29 | $64.00M 10-Q · filed 2016-04-29 | $54.40M derived: sum of 4 quarters · filed 2016-08-05 | |
| 2014-12-31 | $18.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-28 | $28.50M 10-Q · filed 2016-01-28 | $18.90M derived: sum of 3 quarters · filed 2016-08-05 | $28.20M derived: sum of 4 quarters · filed 2016-08-05 | |
| 2014-09-30 | $9.70M 10-Q · filed 2015-10-27 | $100.00K derived: sum of 2 quarters · filed 2016-08-05 | $9.40M derived: sum of 3 quarters · filed 2016-08-05 | $48.40M derived: sum of 4 quarters · filed 2016-08-05 | |
| 2014-06-30 | -$9.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-05 | -$300.00K derived: sum of 2 quarters · filed 2016-08-05 | $38.70M derived: sum of 3 quarters · filed 2016-08-05 | $50.20M 10-K · filed 2016-08-05 | |
| 2014-03-31 | $9.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | $48.30M derived: sum of 2 quarters · filed 2015-04-29 | $59.80M 10-Q · filed 2015-04-29 | $81.10M derived: sum of 4 quarters · filed 2015-08-07 | |
| 2013-12-31 | $39.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-30 | $50.50M 10-Q · filed 2015-01-30 | $71.80M derived: sum of 3 quarters · filed 2015-08-07 | $92.10M derived: sum of 4 quarters · filed 2015-08-07 | |
| 2013-09-30 | $11.50M 10-Q · filed 2014-10-31 | $32.80M derived: sum of 2 quarters · filed 2015-08-07 | $53.10M derived: sum of 3 quarters · filed 2015-08-07 | $67.60M derived: sum of 4 quarters · filed 2015-08-07 | |
| 2013-06-30 | $21.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-07 | $41.60M derived: sum of 2 quarters · filed 2015-08-07 | $56.10M derived: sum of 3 quarters · filed 2015-08-07 | $77.80M 10-K · filed 2015-08-07 | |
| 2013-03-31 | $20.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-01 | $34.80M derived: sum of 2 quarters · filed 2014-05-01 | $56.50M 10-Q · filed 2014-05-01 | $77.90M derived: sum of 4 quarters · filed 2014-08-08 | |
| 2012-12-31 | $14.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-29 | $36.20M 10-Q · filed 2014-01-29 | $57.60M derived: sum of 3 quarters · filed 2014-08-08 | $69.50M derived: sum of 4 quarters · filed 2014-08-08 | |
| 2012-09-30 | $21.70M 10-Q · filed 2013-10-30 | $43.10M derived: sum of 2 quarters · filed 2014-08-08 | $55.00M derived: sum of 3 quarters · filed 2014-08-08 | $61.40M derived: sum of 4 quarters · filed 2014-08-08 | |
| 2012-06-30 | $21.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-08 | $33.30M derived: sum of 2 quarters · filed 2014-08-08 | $39.70M derived: sum of 3 quarters · filed 2014-08-08 | $45.30M 10-K · filed 2014-08-08 | |
| 2012-03-31 | $11.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-01 | $18.30M derived: sum of 2 quarters · filed 2013-05-01 | $23.90M 10-Q · filed 2013-05-01 | $35.80M derived: sum of 4 quarters · filed 2013-08-13 | |
| 2011-12-31 | $6.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-01-31 | $12.00M 10-Q · filed 2013-01-31 | $23.90M derived: sum of 3 quarters · filed 2013-08-13 | $38.30M derived: sum of 4 quarters · filed 2013-08-13 | |
| 2011-09-30 | $5.60M 10-Q · filed 2012-10-31 | $17.50M derived: sum of 2 quarters · filed 2013-08-13 | $31.90M derived: sum of 3 quarters · filed 2013-08-13 | $60.40M derived: sum of 4 quarters · filed 2013-08-13 | |
| 2011-06-30 | $11.90M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-13 | $26.30M derived: sum of 2 quarters · filed 2013-08-13 | $54.80M derived: sum of 3 quarters · filed 2013-08-13 | $66.40M 10-K · filed 2013-08-13 | |
| 2011-03-31 | $14.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-01 | $42.90M derived: sum of 2 quarters · filed 2012-05-01 | $54.50M 10-Q · filed 2012-05-01 | ||
| 2010-12-31 | $28.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-02 | $40.10M 10-Q · filed 2012-02-02 | |||
| 2010-09-30 | $11.60M 10-Q · filed 2011-11-03 | ||||
| 2010-06-30 | $65.30M 10-K · filed 2012-08-14 | ||||
| 2009-06-30 | $17.80M 10-K · filed 2011-08-17 |